CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating

Pharma |  News | 1 Comment | 29 Mar, 2019

CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. A focus on removing long-list products, and the increased use of gen...Read more

Japan approves Gilead’s Biktarvy to treat HIV-1 Infection

Pharma |  News | 0 Comment | 28 Mar, 2019

Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Biktarvy® (bictegravir 50mg/emtricitabine 200mg/tenofovir alafena...Read more

WuXi STA's new facility passes European MPA GMP inspection

Pharma |  News | 0 Comment | 27 Mar, 2019

STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product manufacturing facility in Shanghai Pilot Free Trade Zone has passed it...Read more

Novartis’ Mayzent gets FDA nod to treat multiple sclerosis

Pharma |  News | 0 Comment | 27 Mar, 2019

Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including s...Read more

Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan

Pharma |  News | 0 Comment | 26 Mar, 2019

Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Holdings SA (LAHSA) and Yoshindo Inc. in Japan, and Lupin (through its J...Read more

LegoChem Biosciences, Takeda collaborate for immuno-oncology research

Pharma |  News | 0 Comment | 25 Mar, 2019

LegoChem Biosciences has announced that it has entered a research collaboration and license agreement with Takeda Pharmaceutical for the development of antibody-drug conjugates in immuno-on...Read more

Sosei announces launch of COPD medication in China

Pharma |  News | 0 Comment | 25 Mar, 2019

Sosei Group Corporation confirms that Ultibro® Breezhaler® and Seebri® Breezhaler® have been launched by Novartis in China for the treatment of chronic obstructive pulmonary...Read more

Jazz Pharma gets U.S. FDA approval for a drug that improves wakefulness

Pharma |  News | 0 Comment | 22 Mar, 2019

Jazz Pharmaceuticals plc has announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepi...Read more

60P launches malaria preventive medicine in Australia

Pharma |  News | 0 Comment | 22 Mar, 2019

60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria prevention medicine, Kodatef® (tafenoquine succinate). ...Read more

Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Pharma |  News | 0 Comment | 22 Mar, 2019

Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/dementia pipeline, including anti-amyloid beta (Abeta) protofibril anti...Read more

Hyphens Pharma inks MoU with A*STAR for Derma research

Pharma |  News | 0 Comment | 22 Mar, 2019

Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemical and Engineering Sciences (ICES). By leveraging A*STAR’s res...Read more

Vertex receives approval for CF drug in Australia

Pharma |  News | 0 Comment | 20 Mar, 2019

Vertex Pharmaceuticals Incorporated has announced that the Therapeutic Goods Administration (TGA) of Australia has granted registration to SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) ...Read more

Blackstone to acquire AYUMI Pharmaceutical

Pharma |  News | 0 Comment | 18 Mar, 2019

Blackstone has announced that private equity funds managed by Blackstone have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation, pharmaceutical company in Japa...Read more

Pharmaceutics International gets EIR from FDA

Pharma |  News | 0 Comment | 18 Mar, 2019

Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) has announced that the U.S. Food and Drug Administration (FDA) has issued their Establi...Read more

Théa, OliX to develop RNAi therapies for AMD treatment

Pharma |  News | 0 Comment | 18 Mar, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that it has signed a license and collaboration agreement with Théa Open Innovation, part of the La...Read more

Chugai’s Hemlibra receives approval for severe Hemophilia A

Pharma |  News | 0 Comment | 15 Mar, 2019

Chugai Pharmaceutical has announced that Roche received the decision from the European Commission confirming that Hemlibra® (emicizumab), a hemophilia A treatment originated by Chu...Read more

Aprecia, CMIC to bring 3DP pharmaceutical products to Japan

Pharma |  News | 0 Comment | 15 Mar, 2019

Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both companies will collaborate to develop business opportunities in Jap...Read more

Glenmark receives ANDA approval for Clindamycin and Benzoyl Peroxide Gel, 1%|5%

Pharma |  News | 0 Comment | 15 Mar, 2019

Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a generic versi...Read more